Director, Oncology Strategy & Portfolio Leadership

BioSpace

North Chicago (IL)

On-site

USD 180,000 - 260,000

Full time

7 hours ago

Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

AbbVie in North Chicago, IL is seeking a Senior Director, Project Management to lead long-range portfolio strategy within the Therapeutic Area. You will partner with TA VP, TEC, and ADTs to align development plans with TA strategy and drive value across assets, leveraging external collaborations and innovative tools to accelerate pipeline progression.

The role requires strong strategic thinking, cross-functional leadership, and excellent communication to influence global teams and stakeholders.

Qualifications

Bachelor's degree required; Advanced degree (PharmD, PhD, MD, MBA) highly preferred.
Minimum of 10 years (15+ years preferred) of research/development, commercial, project management, portfolio management, business development, or related experience in the pharmaceutical or biotech industry.
Recognized team player with proven facilitative leadership skills in a cross-functional global team environment.
Proven performance in a matrix environment with ability to influence and align stakeholders.
Excellent interpersonal skills. Ability to interact externally and internally to support business strategy.
Strong analytical skills. Recognized ability to evaluate complex issues from multiple perspectives to ensure that balanced risk assessments are made.
Excellent oral and written communication skills.

Responsibilities

Serves as a core member of the TEC as a strategic partner with TA VP and TEC members, with responsibility for the TEC agenda and areas of focus, driving the overall, long-term TA strategy.
Advises ADTs across the lifecycle, to ensure application of the Playbook and alignment of the Target Product Profile (TPP) and Development Plan with the TA strategy.
Partners with Business Development as Co-lead of Therapy Assessment Teams, and works with Ventures & Early Stage Collaborations to undertake external molecule assessments consistent with TA strategy.
Provides strategic input into the development of Disease Opportunity Profiles (DOPs), cross-functional evaluations of potential Discovery initiatives, and the TA investment thesis.
Coordinates the generation of competitive environment assessments for review at TEC, to turn the data into useful working knowledge for the TEC and disease area in support of the pipeline.
As appropriate, facilitates identification, evaluation, and implementation of novel tools and technologies (e.g., biomarkers, drug delivery systems, devices and other platform technologies, compliance tools, disease monitoring techniques) that can be employed to improve or accelerate pipeline progression in disease areas of interest.
In collaboration with relevant functions, drives internal and external stakeholder assessments in order to anticipate changes in the external environment (e.g. regulatory trends, changing payer environment), and to understand the patient journey and levers to improve outcomes.
Coordinates the conduct and rollup of long-range strategic planning and portfolio documentation for the TA, working in close collaboration with the Clinical TA VP, Decision Support Group (DSG), Commercial and R&D.
Works with TA and TEC leaders to identify, prioritize, and nurture external collaborations (consortia, academic and scientific collaborations, key scientific leader advisors, etc.) in areas where we want to further our understanding of disease pathways and mechanisms. Advances our partnerships and alliances for improved outcomes, creating holistic "Total Patient Solutions".